Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Therapeutic blockade of activin-A improves NK cell function and antitumor immunity.

Rautela J, Dagley LF, de Oliveira CC, Schuster IS, Hediyeh-Zadeh S, Delconte RB, Cursons J, Hennessy R, Hutchinson DS, Harrison C, Kita B, Vivier E, Webb AI, Degli-Esposti MA, Davis MJ, Huntington ND, Souza-Fonseca-Guimaraes F.

Sci Signal. 2019 Aug 27;12(596). pii: eaat7527. doi: 10.1126/scisignal.aat7527.

PMID:
31455725
2.

Context-Dependent Role for T-bet in T Follicular Helper Differentiation and Germinal Center Function following Viral Infection.

Sheikh AA, Cooper L, Feng M, Souza-Fonseca-Guimaraes F, Lafouresse F, Duckworth BC, Huntington ND, Moon JJ, Pellegrini M, Nutt SL, Belz GT, Good-Jacobson KL, Groom JR.

Cell Rep. 2019 Aug 13;28(7):1758-1772.e4. doi: 10.1016/j.celrep.2019.07.034.

3.

Loss-of-Function in SMAD4 Might Not Be Critical for Human Natural Killer Cell Responsiveness to TGF-β.

Healy LP, Rossi GR, Rautela J, Slade CA, Huntington ND, Winship IM, Souza-Fonseca-Guimaraes F.

Front Immunol. 2019 May 1;10:904. doi: 10.3389/fimmu.2019.00904. eCollection 2019.

4.

A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients.

Cursons J, Souza-Fonseca-Guimaraes F, Foroutan M, Anderson A, Hollande F, Hediyeh-Zadeh S, Behren A, Huntington ND, Davis MJ.

Cancer Immunol Res. 2019 Jul;7(7):1162-1174. doi: 10.1158/2326-6066.CIR-18-0500. Epub 2019 May 14.

PMID:
31088844
5.

A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy.

Lelliott EJ, Cullinane C, Martin CA, Walker R, Ramsbottom KM, Souza-Fonseca-Guimaraes F, Abuhammad S, Michie J, Kirby L, Young RJ, Slater A, Lau P, Meeth K, Oliaro J, Haynes N, McArthur GA, Sheppard KE.

Sci Rep. 2019 Feb 4;9(1):1225. doi: 10.1038/s41598-018-37883-y.

6.

The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy.

Souza-Fonseca-Guimaraes F, Cursons J, Huntington ND.

Trends Immunol. 2019 Feb;40(2):142-158. doi: 10.1016/j.it.2018.12.003. Epub 2019 Jan 10. Review.

PMID:
30639050
7.

Recipient BCL2 inhibition and NK cell ablation form part of a reduced intensity conditioning regime that improves allo-bone marrow transplantation outcomes.

Jiao Y, Davis JE, Rautela J, Carrington EM, Ludford-Menting MJ, Goh W, Delconte RB, Souza-Fonseca-Guimaraes F, Koldej R, Gray D, Huang D, Kile BT, Lew AM, Ritchie DS, Huntington ND.

Cell Death Differ. 2019 Aug;26(8):1516-1530. doi: 10.1038/s41418-018-0228-y. Epub 2018 Nov 12.

PMID:
30420758
8.

NLRP1 restricts butyrate producing commensals to exacerbate inflammatory bowel disease.

Tye H, Yu CH, Simms LA, de Zoete MR, Kim ML, Zakrzewski M, Penington JS, Harapas CR, Souza-Fonseca-Guimaraes F, Wockner LF, Preaudet A, Mielke LA, Wilcox SA, Ogura Y, Corr SC, Kanojia K, Kouremenos KA, De Souza DP, McConville MJ, Flavell RA, Gerlic M, Kile BT, Papenfuss AT, Putoczki TL, Radford-Smith GL, Masters SL.

Nat Commun. 2018 Sep 13;9(1):3728. doi: 10.1038/s41467-018-06125-0.

9.

GM-CSF Quantity Has a Selective Effect on Granulocytic vs. Monocytic Myeloid Development and Function.

Sun L, Rautela J, Delconte RB, Souza-Fonseca-Guimaraes F, Carrington EM, Schenk RL, Herold MJ, Huntington ND, Lew AM, Xu Y, Zhan Y.

Front Immunol. 2018 Aug 28;9:1922. doi: 10.3389/fimmu.2018.01922. eCollection 2018.

10.

Generation of novel Id2 and E2-2, E2A and HEB antibodies reveals novel Id2 binding partners and species-specific expression of E-proteins in NK cells.

Rautela J, Dagley LF, Kratina T, Anthony A, Goh W, Surgenor E, Delconte RB, Webb AI, Elwood N, Groom JR, Souza-Fonseca-Guimaraes F, Corcoran L, Huntington ND.

Mol Immunol. 2018 Aug 23. pii: S0161-5890(18)30681-3. doi: 10.1016/j.molimm.2018.08.017. [Epub ahead of print]

PMID:
30144957
11.

Molecular insight into targeting the NK cell immune response to cancer.

Rautela J, Souza-Fonseca-Guimaraes F, Hediyeh-Zadeh S, Delconte RB, Davis MJ, Huntington ND.

Immunol Cell Biol. 2018 May;96(5):477-484. doi: 10.1111/imcb.12045. Epub 2018 Apr 17. Review.

PMID:
29577414
12.

Rapid loss of group 1 innate lymphoid cells during blood stage Plasmodium infection.

Ng SS, Souza-Fonseca-Guimaraes F, Rivera FL, Amante FH, Kumar R, Gao Y, Sheel M, Beattie L, Montes de Oca M, Guillerey C, Edwards CL, Faleiro RJ, Frame T, Bunn PT, Vivier E, Godfrey DI, Pellicci DG, Lopez JA, Andrews KT, Huntington ND, Smyth MJ, McCarthy J, Engwerda CR.

Clin Transl Immunology. 2018 Jan 12;7(1):e1003. doi: 10.1002/cti2.1003. eCollection 2018.

13.

A new checkpoint for Natural Killer cell activation.

Souza-Fonseca-Guimaraes F, Huntington ND.

Immunol Cell Biol. 2018 Jan;96(1):5-7. doi: 10.1111/imcb.1027. Epub 2017 Dec 15. No abstract available.

PMID:
29356093
14.

A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment.

Young A, Ngiow SF, Gao Y, Patch AM, Barkauskas DS, Messaoudene M, Lin G, Coudert JD, Stannard KA, Zitvogel L, Degli-Esposti MA, Vivier E, Waddell N, Linden J, Huntington ND, Souza-Fonseca-Guimaraes F, Smyth MJ.

Cancer Res. 2018 Feb 15;78(4):1003-1016. doi: 10.1158/0008-5472.CAN-17-2826. Epub 2017 Dec 11.

15.

Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.

Gao Y, Souza-Fonseca-Guimaraes F, Bald T, Ng SS, Young A, Ngiow SF, Rautela J, Straube J, Waddell N, Blake SJ, Yan J, Bartholin L, Lee JS, Vivier E, Takeda K, Messaoudene M, Zitvogel L, Teng MWL, Belz GT, Engwerda CR, Huntington ND, Nakamura K, Hölzel M, Smyth MJ.

Nat Immunol. 2017 Sep;18(9):1004-1015. doi: 10.1038/ni.3800. Epub 2017 Jul 31.

PMID:
28759001
16.

NK cell heparanase controls tumor invasion and immune surveillance.

Putz EM, Mayfosh AJ, Kos K, Barkauskas DS, Nakamura K, Town L, Goodall KJ, Yee DY, Poon IK, Baschuk N, Souza-Fonseca-Guimaraes F, Hulett MD, Smyth MJ.

J Clin Invest. 2017 Jun 30;127(7):2777-2788. doi: 10.1172/JCI92958. Epub 2017 Jun 5.

17.

Single-cell RNA-seq and computational analysis using temporal mixture modelling resolves Th1/Tfh fate bifurcation in malaria.

Lönnberg T, Svensson V, James KR, Fernandez-Ruiz D, Sebina I, Montandon R, Soon MS, Fogg LG, Nair AS, Liligeto U, Stubbington MJ, Ly LH, Bagger FO, Zwiessele M, Lawrence ND, Souza-Fonseca-Guimaraes F, Bunn PT, Engwerda CR, Heath WR, Billker O, Stegle O, Haque A, Teichmann SA.

Sci Immunol. 2017 Mar 3;2(9). pii: eaal2192. doi: 10.1126/sciimmunol.aal2192. Erratum in: Sci Immunol. 2018 Mar 9;3(21):.

18.

Natural Killer Cell Assessment in Peripheral Circulation and Bronchoalveolar Lavage Fluid of Patients with Severe Sepsis: A Case Control Study.

Souza-Fonseca-Guimaraes P, Guimaraes F, Natânia De Souza-Araujo C, Maria Boldrini Leite L, Cristina Senegaglia A, Nishiyama A, Souza-Fonseca-Guimaraes F.

Int J Mol Sci. 2017 Mar 12;18(3). pii: E616. doi: 10.3390/ijms18030616.

19.

Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival.

Viant C, Guia S, Hennessy RJ, Rautela J, Pham K, Bernat C, Goh W, Jiao Y, Delconte R, Roger M, Simon V, Souza-Fonseca-Guimaraes F, Grabow S, Belz GT, Kile BT, Strasser A, Gray D, Hodgkin PD, Beutler B, Vivier E, Ugolini S, Huntington ND.

J Exp Med. 2017 Feb;214(2):491-510. doi: 10.1084/jem.20160869. Epub 2017 Jan 5.

20.

GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity.

Bunting MD, Varelias A, Souza-Fonseca-Guimaraes F, Schuster IS, Lineburg KE, Kuns RD, Fleming P, Locke KR, Huntington ND, Blazar BR, Lane SW, Tey SK, MacDonald KP, Smyth MJ, Degli-Esposti MA, Hill GR.

Blood. 2017 Feb 2;129(5):630-642. doi: 10.1182/blood-2016-08-734020. Epub 2016 Dec 7.

21.

IFNAR1-Signalling Obstructs ICOS-mediated Humoral Immunity during Non-lethal Blood-Stage Plasmodium Infection.

Sebina I, James KR, Soon MS, Fogg LG, Best SE, Labastida Rivera F, Montes de Oca M, Amante FH, Thomas BS, Beattie L, Souza-Fonseca-Guimaraes F, Smyth MJ, Hertzog PJ, Hill GR, Hutloff A, Engwerda CR, Haque A.

PLoS Pathog. 2016 Nov 3;12(11):e1005999. doi: 10.1371/journal.ppat.1005999. eCollection 2016 Nov.

22.

Autophagy-dependent regulatory T cells are critical for the control of graft-versus-host disease.

Le Texier L, Lineburg KE, Cao B, McDonald-Hyman C, Leveque-El Mouttie L, Nicholls J, Melino M, Nalkurthi BC, Alexander KA, Teal B, Blake SJ, Souza-Fonseca-Guimaraes F, Engwerda CR, Kuns RD, Lane SW, Teng M, Teh C, Gray D, Clouston AD, Nilsson SK, Blazar BR, Hill GR, MacDonald KP.

JCI Insight. 2016 Sep 22;1(15):e86850. doi: 10.1172/jci.insight.86850.

23.

Anti-CD137 enhances anti-CD20 therapy of systemic B-cell lymphoma with altered immune homeostasis but negligible toxicity.

Souza-Fonseca-Guimaraes F, Blake SJ, Makkouk A, Chester C, Kohrt HE, Smyth MJ.

Oncoimmunology. 2016 Jun 30;5(7):e1192740. doi: 10.1080/2162402X.2016.1192740. eCollection 2016 Jul.

24.

Granzyme M has a critical role in providing innate immune protection in ulcerative colitis.

Souza-Fonseca-Guimaraes F, Krasnova Y, Putoczki T, Miles K, MacDonald KP, Town L, Shi W, Gobe GC, McDade L, Mielke LA, Tye H, Masters SL, Belz GT, Huntington ND, Radford-Smith G, Smyth MJ.

Cell Death Dis. 2016 Jul 21;7:e2302. doi: 10.1038/cddis.2016.215.

25.

NK cell-based immunotherapies: awakening the innate anti-cancer response.

Souza-Fonseca-Guimaraes F.

Discov Med. 2016 Mar;21(115):197-203. Review.

26.

Pravastatin induces cell cycle arrest and decreased production of VEGF and bFGF in multiple myeloma cell line.

Trojan PJ, Bohatch-Junior MS, Otuki MF, Souza-Fonseca-Guimarães F, Svidnicki PV, Nogaroto V, Fernandes D, Krum EA, Favero GM.

Braz J Biol. 2016 Feb;76(1):59-65. doi: 10.1590/1519-6984.11914. Epub 2016 Jan 22.

27.

Inhalation therapy with M1 inhibits experimental melanoma development and metastases in mice.

Ferrari de Andrade L, Mozeleski B, Leck AR, Rossi G, da Costa CR, de Souza Fonseca Guimarães F, Zotz R, Fialho do Nascimento K, Camargo de Oliveira C, de Freitas Buchi D, da Silva Trindade E.

Homeopathy. 2016 Feb;105(1):109-18. doi: 10.1016/j.homp.2015.08.007. Epub 2015 Sep 26.

PMID:
26828006
28.

Bench to bedside: NK cells and control of metastasis.

Krasnova Y, Putz EM, Smyth MJ, Souza-Fonseca-Guimaraes F.

Clin Immunol. 2017 Apr;177:50-59. doi: 10.1016/j.clim.2015.10.001. Epub 2015 Oct 23. Review.

PMID:
26476139
29.

IFN type III: in vivo NK cell response.

Souza-Fonseca-Guimaraes F, Young A, Smyth MJ.

Oncotarget. 2015 Aug 21;6(24):19960-1. No abstract available.

30.

NK cells require IL-28R for optimal in vivo activity.

Souza-Fonseca-Guimaraes F, Young A, Mittal D, Martinet L, Bruedigam C, Takeda K, Andoniou CE, Degli-Esposti MA, Hill GR, Smyth MJ.

Proc Natl Acad Sci U S A. 2015 May 5;112(18):E2376-84. doi: 10.1073/pnas.1424241112. Epub 2015 Apr 21.

31.

DNAM-1 expression marks an alternative program of NK cell maturation.

Martinet L, Ferrari De Andrade L, Guillerey C, Lee JS, Liu J, Souza-Fonseca-Guimaraes F, Hutchinson DS, Kolesnik TB, Nicholson SE, Huntington ND, Smyth MJ.

Cell Rep. 2015 Apr 7;11(1):85-97. doi: 10.1016/j.celrep.2015.03.006. Epub 2015 Mar 26.

32.

CD3bright signals on γδ T cells identify IL-17A-producing Vγ6Vδ1+ T cells.

Paget C, Chow MT, Gherardin NA, Beavis PA, Uldrich AP, Duret H, Hassane M, Souza-Fonseca-Guimaraes F, Mogilenko DA, Staumont-Sallé D, Escalante NK, Hill GR, Neeson P, Ritchie DS, Dombrowicz D, Mallevaey T, Trottein F, Belz GT, Godfrey DI, Smyth MJ.

Immunol Cell Biol. 2015 Feb;93(2):198-212. doi: 10.1038/icb.2014.94. Epub 2014 Nov 11.

33.

Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells.

Sathe P, Delconte RB, Souza-Fonseca-Guimaraes F, Seillet C, Chopin M, Vandenberg CJ, Rankin LC, Mielke LA, Vikstrom I, Kolesnik TB, Nicholson SE, Vivier E, Smyth MJ, Nutt SL, Glaser SP, Strasser A, Belz GT, Carotta S, Huntington ND.

Nat Commun. 2014 Aug 14;5:4539. doi: 10.1038/ncomms5539.

PMID:
25119382
34.

The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.

Chan CJ, Martinet L, Gilfillan S, Souza-Fonseca-Guimaraes F, Chow MT, Town L, Ritchie DS, Colonna M, Andrews DM, Smyth MJ.

Nat Immunol. 2014 May;15(5):431-8. doi: 10.1038/ni.2850. Epub 2014 Mar 23.

PMID:
24658051
35.

CD24-triggered caspase-dependent apoptosis via mitochondrial membrane depolarization and reactive oxygen species production of human neutrophils is impaired in sepsis.

Parlato M, Souza-Fonseca-Guimaraes F, Philippart F, Misset B; Captain Study Group, Adib-Conquy M, Cavaillon JM.

J Immunol. 2014 Mar 1;192(5):2449-59. doi: 10.4049/jimmunol.1301055. Epub 2014 Feb 5.

36.

TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals.

Adib-Conquy M, Scott-Algara D, Cavaillon JM, Souza-Fonseca-Guimaraes F.

Immunol Cell Biol. 2014 Mar;92(3):256-62. doi: 10.1038/icb.2013.99. Epub 2013 Dec 24. Review.

PMID:
24366517
37.

Bench-to-bedside review: Natural killer cells in sepsis - guilty or not guilty?

Souza-Fonseca-Guimaraes F, Cavaillon JM, Adib-Conquy M.

Crit Care. 2013 Aug 27;17(4):235. doi: 10.1186/cc12700. Review.

38.

Myeloid TGF-β responsiveness promotes metastases.

Souza-Fonseca-Guimaraes F, Smyth MJ.

Cancer Discov. 2013 Aug;3(8):846-8. doi: 10.1158/2159-8290.CD-13-0271.

39.

Interferon-γ and granulocyte/monocyte colony-stimulating factor production by natural killer cells involves different signaling pathways and the adaptor stimulator of interferon genes (STING).

Souza-Fonseca-Guimaraes F, Parlato M, de Oliveira RB, Golenbock D, Fitzgerald K, Shalova IN, Biswas SK, Cavaillon JM, Adib-Conquy M.

J Biol Chem. 2013 Apr 12;288(15):10715-21. doi: 10.1074/jbc.M112.435602. Epub 2013 Feb 26.

40.

Toll-like receptors expression and interferon-γ production by NK cells in human sepsis.

Souza-Fonseca-Guimaraes F, Parlato M, Philippart F, Misset B, Cavaillon JM, Adib-Conquy M; Captain study group.

Crit Care. 2012 Oct 25;16(5):R206. doi: 10.1186/cc11838.

41.

NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis.

Souza-Fonseca-Guimaraes F, Parlato M, Fitting C, Cavaillon JM, Adib-Conquy M.

J Immunol. 2012 Jun 15;188(12):5850-8. doi: 10.4049/jimmunol.1103616. Epub 2012 May 7.

42.

Brown spider (Loxosceles intermedia) venom triggers endothelial cells death by anoikis.

Nowatzki J, Sene RV, Paludo KS, Rizzo LE, Souza-Fonseca-Guimarães F, Veiga SS, Nader HB, Franco CR, Trindade ES.

Toxicon. 2012 Sep 1;60(3):396-405. doi: 10.1016/j.toxicon.2012.04.333. Epub 2012 Apr 19.

PMID:
22538195
43.

Natural killer (NK) cells in antibacterial innate immunity: angels or devils?

Souza-Fonseca-Guimaraes F, Adib-Conquy M, Cavaillon JM.

Mol Med. 2012 Mar 30;18:270-85. doi: 10.2119/molmed.2011.00201. Review.

44.

Effectiveness of Vernonia scorpioides ethanolic extract against skin inflammatory processes.

Rauh LK, Horinouchi CD, Loddi AM, Pietrovski EF, Neris R, Souza-Fonseca-Guimarães F, Buchi DF, Biavatti MW, Otuki MF, Cabrini DA.

J Ethnopharmacol. 2011 Nov 18;138(2):390-7. doi: 10.1016/j.jep.2011.09.012. Epub 2011 Sep 21.

45.

Genome size evaluation in Tetraodontiform fishes from the Neotropical region.

Noleto RB, de Souza Fonseca Guimarães F, Paludo KS, Vicari MR, Artoni RF, Cestari MM.

Mar Biotechnol (NY). 2009 Nov-Dec;11(6):680-5. doi: 10.1007/s10126-009-9215-0. Epub 2009 Jul 10.

PMID:
19590923

Supplemental Content

Loading ...
Support Center